Organic phenyl arsonic acid compounds with potent antileukemic activity

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 3, 2003, Pages 581-583

  Liu, Xing Ping ^a   Narla, Rama Krishna ^a   Uckun, Fatih M ^a  

^a Parker Hughes Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIO 4 (2' PHENYLARSONIC ACID)AMINOPYRIMIDINE; 2 TRICHLOROMETHYL 4 [4' (4'' PHENYLAZO)PHENYLARSONIC ACID]AMINOQUINAZOLINE; ARSONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; POLYMERIZATION;

ANTINEOPLASTIC AGENTS; ARSENICALS; CELL LINEAGE; GENES, P53; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0037328510     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00928-9     Document Type: Article

References (19)

1. Uckun F.M., Sather H.N., Gaynon P.S., Arthur D.C., Trigg M.E., Tubergen D.G., Nachman J., Steinherz P.G., Sensel M.G., Reaman G.H. Blood. 90:1997;28.
2. Uckun F.M., Herman-Hatten K., Crotty M.L., Sensel M.G., Sather H.N., Tuel-Ahlgren L., Sarquis M.B., Bostrom B., Nachman J.B., Steinherz P.G., Gaynon P.S., Heerema N. Blood. 92:1998;810.
3. Uckun F.M., Kersey J.H., Haake R., Weisdorf D., Nesbit M.E., Ramsay N.K. N. Engl. J. Med. 329:1993;1296.
4. Chen G.Q., Zhu J., Shi X.G., Ni J.H., Zhong H.J., Si G.Y., Jin X.L., Tang W., Li X.S., Xong S.M., Shen Z.X., Sun G.L., Ma J., Zhang P., Zhang T.D., Gazin C., Naoe T., Chen S.J., Wang Z.Y., Chen Z. Blood. 88:1996;1052.
5. Shen Z.X., Chen G.Q., Ni J.H., Li X.S., Xiong S.M., Qiu Q.Y., Zhu J., Tang W., Sun G.L., Yang K.Q., Chen Y., Zhou L., Fang Z.W., Wang Y.T., Ma J., Zhang P., Zhang T.D., Chen S.J., Chen Z., Wang Z.Y. Blood. 89:1997;3354.
6. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrell R.P. N. Engl. J. Med. 339:1998;1341.
7. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., Waxman S. Blood. 94:1999;2102.
8. Zhu X.H., Shen Y.L., Jing Y.K., Cai X., Jia P.M., Huang Y., Tang W., Shi G.Y., Sun Y.P., Dai J., Wang Z.Y., Chen S.J., Zhang T.D., Waxman S., Chen Z., Chen G.Q. J. Natl. Cancer Inst. 91:1999;772.
9. Dai J., Weinberg R.S., Waxman S., Jing Y. Blood. 93:1999;268.
10. The National Academy of Sciences-National Research Council: Washington, DC, 1980; p 40.
11. Nomoto F., Obase H., Takai H., Hirata T., Teranishi M., Nakamura J., Kubo K. Chem. Pharm. Bull. 38:1990;1691.
12. Thomas C.L. Catalytic Processes and Proven Catalysts. 1970;Academic, New York.
13. Satoh T., Suzuki S., Suzuki Y., Miyaji Y., Imai Z. Tetrahedron Lett. 52:1969;4555.
14. Yuki H., Kishikawa T., Tohira Y., Watanabe K. Chem. Pharm. Bull. 15:1967;1052.
15. Andres R.J., Hamilton C.S. J. Am. Chem. Soc. 67:1945;946.
16. 3 ·4HCl requires: C, 35.54, H, 2.68, N, 9.87%.
17. Narla R.K., Liu X.P., Myers D.E., Uckun F.M. Clin. Cancer Res. 4:1998;1405.
18. Uckun F.M., Evans W.E., Forsyth C.J., Waddick K.G., Ahlgren L.T., Chelstrom L.M., Burkhardt A., Bolen J., Myers D.E. Science. 267:1995;886.
19. Uckun F.M., Chandan-Langlie M., Dockham P.A., Aeppli D., Sladek N.E. Leuk. Lymphoma. 13:1994;417.